Reliance Life Sciences Private Limited: Pemetrexed For Injection 500mg/vial, 1

Recall Summary Pemetrexed for Injection 500mg/Vial (a cancer medication) manufactured by Reliance Life Sciences and distributed nationwide under the Somerset Therapeutics brand is being recalled because it lacks proper sterility assurance, meaning the product may not be sterile. This is a Class II recall affecting all 50 states and Washington, D.C.

Recalling firm
Reliance Life Sciences Private Limited
Product
Pemetrexed for Injection 500mg/Vial, 1 50 mL Single-Dose Vial per carton, For intravenous use only, Rx only, Manufactured for: Somerset Therapeutics, LLC., Somerset, NJ 08873 NDC: 70069-0835-01
Reason
Lack of Sterility Assurance
Classification
Class II
Category
drug recall
Country
United States
Agency
U.S. Food and Drug Administration
Recall date
2026-06-24
Status
Ongoing
Areas affected
AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, ...
Distribution
Nationwide in the USA

Official recall notice from U.S. Food and Drug Administration

Recall details on Nibble Recalls: https://trynibble.app/recalls/6250f6d9-c52f-4962-8f2c-55cc9d903317